On the public citation graph

The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics

https://doi.org/10.1007/bf00315518
0 signed · 32 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archinte.149.7.1514openalex-snapshot
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
inferredcites →https://doi.org/10.1001/archinte.1989.00390070054005openalex-snapshot
The Deadly Quartet
inferredcites →https://doi.org/10.1007/bf00257728openalex-snapshot
Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid Chromatographic assay
inferredcites →https://doi.org/10.1007/bf00561783openalex-snapshot
Behaviour of glibenclamide on repeated administration to diabetic patients
inferredcites →https://doi.org/10.1016/s0002-9343(85)80010-3openalex-snapshot
Pharmacokinetics of glyburide
inferredcites →https://doi.org/10.1023/a:1015819105699openalex-snapshot
Solute Absorption from the Airways of the Isolated Rat Lung. II. Effect of Surfactants on Absorption of Fluorescein
inferredcites →https://doi.org/10.1177/106002807400801104openalex-snapshot
Clinical Pharmacy: Case Studies
inferredcites →https://doi.org/10.2165/00003088-198106030-00003openalex-snapshot
Clinical Pharmacokinetics of Sulphonylurea Hypoglycaemic Drugs
inferredcites →https://doi.org/10.2165/00003088-198611030-00002openalex-snapshot
Drug Disposition in Obese Humans
inferredcites →https://doi.org/10.2337/diacare.14.3.173openalex-snapshot
Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4765193openalex-extracted
Synergistic Effects of Sulfonylureas with Chemotherapeutics: In Vitro Screening Reveals Enhanced Cytotoxicity of Doxorubicin in Combination with Sulfonylureas
inferred← citeshttps://doi.org/10.1002/j.1875-9114.1998.tb03826.xopenalex-snapshot
Population Pharmacokinetics of Glyburide in Patients with Well‐Controlled Diabetes
inferred← citeshttps://doi.org/10.1002/jps.22819openalex-snapshot
Prediction of Steady-State Volume of Distribution of Acidic Drugs by Quantitative Structure–Pharmacokinetics Relationships
inferred← citeshttps://doi.org/10.1002/msj.20072openalex-snapshot
Impact of obesity on hospitalized patients
inferred← citeshttps://doi.org/10.1007/978-1-59259-781-9_6openalex-snapshot
Influence of Obesity on Drug Disposition and Effect
inferred← citeshttps://doi.org/10.1007/978-1-60327-362-6_7openalex-snapshot
Influence of Overweight and Obesity on Medication
inferred← citeshttps://doi.org/10.1007/978-3-662-09127-2_9openalex-snapshot
Clinical Pharmacology of Sulfonylureas
inferred← citeshttps://doi.org/10.1007/s00280-019-03979-zopenalex-snapshot
Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors
inferred← citeshttps://doi.org/10.1007/s13318-026-01020-2openalex-snapshot
Population Pharmacokinetic Modeling Study of Glibenclamide in Chinese Healthy Volunteers
inferred← citeshttps://doi.org/10.1016/j.cjca.2014.10.025openalex-snapshot
The Impact of Obesity on the Pharmacology of Medications Used for Cardiovascular Risk Factor Control
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.119009openalex-snapshot
Sulfonylureas beyond diabetes: A comprehensive review on anticancer and off-target effects (1956–2025)
inferred← citeshttps://doi.org/10.1016/j.fct.2003.10.003openalex-snapshot
Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation)
inferred← citeshttps://doi.org/10.1080/17425255.2022.2132931openalex-snapshot
Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes
inferred← citeshttps://doi.org/10.1097/00007691-199602000-00002openalex-snapshot
The Effects of Obesity on the Pharmacokinetics and Pharmacodynamics of Glipizide in Patients with Non-Insulin-Dependent Diabetes Mellitus
inferred← citeshttps://doi.org/10.1111/j.1365-2125.2004.02157.xopenalex-snapshot
What is the best size descriptor to use for pharmacokinetic studies in the obese?
inferred← citeshttps://doi.org/10.1111/j.1365-2710.1995.tb00664.xopenalex-snapshot
Comparison of the kinetics of glyburide and its active metabolites in humans
inferred← citeshttps://doi.org/10.1136/adc.2009.163055openalex-snapshot
Dosing dilemmas in obese children
inferred← citeshttps://doi.org/10.18433/jpps32488openalex-snapshot
Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?
inferred← citeshttps://doi.org/10.2165/00003088-200039030-00004openalex-snapshot
Effects of Obesity on Pharmacokinetics
inferred← citeshttps://doi.org/10.2165/11599410-000000000-00000openalex-snapshot
Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
inferred← citeshttps://doi.org/10.3390/ijms26041429openalex-snapshot
Combining Sulfonylureas with Anticancer Drugs: Evidence of Synergistic Efficacy with Doxorubicin In Vitro and In Vivo
inferred← citeshttps://doi.org/10.70675/e35d8a2dz844fz4cfdz8f64z0870e357ae1fopenalex-snapshot
Evaluation de différents descripteurs de poids chez le sujet obèse à l’aide d’un modèle de pharmacocinétique de population - application à la metformine, la morphine et l’imatinib
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.